Navigation Links
Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Litigation for American Medical Systems Mesh Lawsuits

New York, New York (PRWEB) August 12, 2013

Transvaginal mesh lawsuits ( filed on behalf of women who were allegedly injured as a result of pelvic mesh products marketed by American Medical Systems, Inc. continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued on July 29th, the Court has granted the parties’ Joint Motion for an Agreed Order and Stipulation Regarding Third-Party Subpoenas. Court documents indicate that more than 8,860 vaginal mesh lawsuits are now pending against American Medical Systems in the federal litigation. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee for this proceeding. (In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325)

“Our Firm is representing numerous women in transvaginal mesh lawsuits involving products manufactured by American Medical Systems. We are looking forward to additional progress in this litigation in the months to come,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free vaginal mesh lawsuit reviews to women who have suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to pelvic mesh devices used in the treatment of pelvic organ prolapse and stress urinary incontinence.

Transvaginal Mesh Lawsuits
The litigation surrounding transvaginal mesh has been growing since October 2008, when the U.S. Food & Drug Administration (FDA) issued its first of two alerts regarding the potential dangers associated with the use of such devices. All of the mesh lawsuits pending in the American Medical Systems litigation allege the company failed to provide adequate warnings regarding the risks associated with its transvaginal mesh devices. According to court documents, the first bellwether trial of an American Medical Systems vaginal mesh lawsuit is set to begin in December.

Court records indicate that more than 20,000 mesh lawsuits have been filed against a number of other implant manufacturers in separate litigations underway in the Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committees for proceedings involving Boston Scientific Corp., (MDL No. 2326); C.R. Bard, Inc., (MDL No. 2187), and In re: Ethicon, Inc. (MDL No. 2327).

Mr. Grand has also been named Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon transvaginal mesh lawsuits that are currently underway in New Jersey’s Atlantic County Superior Court, and was a member of the trial team on the first Ethicon trial in that proceeding, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Victims of serious transvaginal mesh complications may be entitled to compensation for their injury-related medical bills, pain and suffering, lost wages and other damages. Learn More about vaginal mesh at Bernstein Liebhard LLP’s website. To contact the Firm for a free vaginal mesh lawsuit review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vaginal Mesh Lawsuit Lawyers at Wright & Schulte LLC Report on Developments in First Federal Trial of C.R. Bard Vaginal Mesh Lawsuit
2. Mesh Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Boston Scientific Transvaginal Mesh Litigation
3. Mesh Lawsuits Move Forward, as Federal Multidistrict Litigation Prepares for First Bellwether Trials in Ethicon Vaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports
4. Transvaginal Mesh Lawsuit News: Plaintiffs’ Expert Witnesses Testify in Bard Trial, Rottenstein Law Group LLP Reports
5. Vaginal Mesh Lawsuit Bellwether Trial Is Underway As Jury Selection Is Finalized, Reports Wright & Schulte
6. Mesh Lawsuit Trial: Bernstein Liebhard LLP Notes Selection of Jury in Federal C.R. Bard Vaginal Mesh Lawsuit Trial
7. Mesh Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Ethicon Vaginal Mesh Lawsuits
8. New Update on Alleged Transvaginal Mesh Complications Lawsuits: First Federal Trial Involving Allegations of Serious Side Effects from C.R. Bard Mesh Scheduled to Begin
9. Mesh Lawsuit – Bellwether Cases Selected in Federal Litigation Underway for Ethicon Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports
10. Mesh Lawsuit - First Bellwether Trial in Federal C.R. Bard Transvaginal Mesh Litigation Set to Begin Monday, Bernstein Liebhard LLP Reports
11. Vaginal Mesh Lawsuit Lawyers at Wright & Schulte LLC Update Status of C.R. Bard Avaulta Transvaginal Mesh Lawsuit Litigation Following Mistrial
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: